---
title: "Shalby Ltd (SHALBY) — Share Price, Financials & Analysis"
symbol: "SHALBY"
company: "Shalby Ltd"
canonical: "https://tapetide.com/stocks/SHALBY"
isin: "INE597J01018"
nse_symbol: "SHALBY"
bse_code: "540797"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 1553.72
generated_at: "2026-09-13T18:36:11.927Z"
---

# Shalby Ltd (SHALBY)

Canonical page: https://tapetide.com/stocks/SHALBY

## Company

- **NSE Symbol:** SHALBY
- **BSE Code:** 540797
- **ISIN:** INE597J01018
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2017-12-15
- **CEO:** Dr. Vikram I. Shah
- **Employees:** 2592
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** shalby.org

## About

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]
The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.

## Latest Price

- **Price:** ₹144.78
- **Change:** -1.18 (-0.81%)
- **Open:** ₹145.25
- **Day High:** ₹146.99
- **Day Low:** ₹141.7
- **Previous Close:** ₹145.96
- **Volume:** 112748
- **As Of:** 2026-09-11T09:59:56+00:00

## Key Fundamentals

Observed at 2026-09-11T04:51:06.457132Z.

- **Market Cap:** ₹1553.72 Cr
- **Classification:** Microcap
- **P/E (reported):** 42.3
- **P/E (TTM):** 39.77
- **EPS (TTM):** ₹3.64
- **EPS (reported):** ₹7.22
- **Book Value:** ₹93.11
- **Price to Book:** 1.57
- **Dividend Yield:** 0.82%
- **ROE:** 3.45%
- **ROCE:** 7.88%
- **Debt to Equity:** 0.59
- **Revenue (yearly):** ₹1168.2 Cr
- **Net Income:** ₹34.7 Cr
- **EBITDA:** ₹169.5 Cr
- **52-Week High:** ₹274.7
- **52-Week Low:** ₹125.82
- **RSI (14):** 27.93

## Tapetide Score

- **Score:** 40 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Falling
- **Percentile:** 14.5 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 24.19 | 9% |
| growth | 26.66 | 9% |
| momentum | 30.22 | 12% |
| ownership | 58.2 | 24% |
| quality | 26.98 | 22% |
| valuation | 51.23 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company's working capital requirements have reduced from 32.0 days to 21.7 days

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 3.11% over last 3 years.
- Dividend payout has been low at 5.11% of profits over last 3 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 99.77% | -100.05% | -100.05% |
| ebitda margin growth | 31.02% | 0.97% | -29.6% | -22.03% |
| net income growth | -43.24% | — | -28% | -11% |
| revenue growth | 14.59% | 4.81% | 12% | 22% |
| roce | 59.74% | 4.1% | -29.83% | 9.05% |
| roe | -43.09% | — | 3.98% | -43.99% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 238 | 216 | 244 | 279 | 268 | 276 | 265 | 296 | 285 | 272 | 287 | 331 |
| Expenses | 185 | 174 | 205 | 234 | 235 | 242 | 244 | 255 | 244 | 242 | 258 | 290 |
| Operating Profit | 53 | 42 | 39 | 45 | 33 | 34 | 21 | 42 | 42 | 30 | 29 | 42 |
| OPM % | 22 | 20 | 16 | 16 | 12 | 12 | 8 | 14 | 15 | 11 | 10 | 13 |
| Other Income | 5 | 5 | 5 | 10 | 7 | 5 | 5 | 7 | 4 | 7 | 8 | 7 |
| Interest | 3 | 4 | 6 | 8 | 9 | 11 | 11 | 9 | 10 | 11 | 9 | 11 |
| Depreciation | 12 | 12 | 16 | 16 | 17 | 16 | 16 | 17 | 17 | 18 | 18 | 19 |
| Profit before tax | 43 | 31 | 22 | 30 | 14 | 12 | -1 | 23 | 19 | 9 | 10 | 20 |
| Tax % | 35 | 38 | 26 | 52 | 83 | 124 | 1547 | 66 | 62 | 86 | -92 | 47 |
| Net Profit | 28 | 19 | 16 | 15 | 2 | -3 | -12 | 8 | 7 | 1 | 18 | 10 |
| EPS in Rs | 2.55 | 1.77 | 1.54 | 1.45 | 0.31 | -0.17 | -1.02 | 0.83 | 0.78 | 0.16 | 1.7 | 1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 378 | 462 | 487 | 431 | 699 | 805 | 934 | 1087 | 1141 | 1176 |
| Expenses | 299 | 379 | 404 | 342 | 577 | 667 | 755 | 952 | 996 | 1033 |
| Operating Profit | 79 | 83 | 83 | 89 | 122 | 138 | 179 | 135 | 145 | 143 |
| OPM % | 21 | 18 | 17 | 21 | 17 | 17 | 19 | 12 | 13 | 12 |
| Other Income | 10 | 9 | 17 | 8 | 8 | 22 | 19 | 28 | 27 | 27 |
| Interest | 12 | 9 | 7 | 5 | 8 | 11 | 18 | 41 | 41 | 40 |
| Depreciation | 23 | 33 | 36 | 37 | 43 | 48 | 52 | 66 | 70 | 72 |
| Profit before tax | 54 | 50 | 57 | 55 | 79 | 102 | 128 | 56 | 61 | 58 |
| Tax % | 27 | 37 | 51 | 23 | 32 | 34 | 35 | 97 | 43 | — |
| Net Profit | 39 | 32 | 28 | 42 | 54 | 68 | 84 | 2 | 35 | 38 |
| EPS in Rs | 3.65 | 2.93 | 2.55 | 3.93 | 5.01 | 6.27 | 7.78 | 0.58 | 3.46 | 3.64 |
| Dividend Payout % | 0 | 17 | 20 | 25 | 20 | 19 | 15 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 87 | 108 | 108 | 108 | 108 | 108 | 107 | 107 | 107 | 108 |
| Reserves | 164 | 643 | 672 | 691 | 727 | 768 | 820 | 893 | 885 | 898 |
| Borrowings | 328 | 114 | 71 | 62 | 44 | 155 | 180 | 378 | 476 | 595 |
| Other Liabilities | 99 | 96 | 89 | 105 | 118 | 162 | 173 | 231 | 241 | 248 |
| Total Liabilities | 679 | 961 | 939 | 967 | 997 | 1194 | 1281 | 1609 | 1709 | 1848 |
| Fixed Assets | 323 | 650 | 692 | 672 | 660 | 675 | 685 | 966 | 955 | 1046 |
| CWIP | 221 | 47 | 3 | 6 | 8 | 6 | 11 | 15 | 22 | 19 |
| Investments | 0 | 0 | 11 | 28 | 16 | 25 | 146 | 81 | 95 | 62 |
| Other Assets | 134 | 264 | 233 | 260 | 314 | 488 | 440 | 547 | 637 | 721 |
| Total Assets | 679 | 961 | 939 | 967 | 997 | 1194 | 1281 | 1609 | 1709 | 1848 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 60 | 14 | 43 | 55 | 79 | 19 | 68 | 20 | -4 | 0 |
| Cash from Investing Activity | -153 | -236 | 1 | -31 | -51 | -60 | -61 | 146 | -36 | -97 |
| Cash from Financing Activity | 96 | 222 | -51 | -22 | -30 | 90 | -50 | -151 | 48 | 84 |
| Net Cash Flow | 3 | 0 | -6 | 3 | -2 | 49 | -43 | 15 | 8 | -13 |
| Free Cash Flow | -98 | -124 | 12 | 244 | 58 | -56 | 50 | -26 | -74 | -145 |
| CFO/OP | 99 | 34 | 63 | 91 | 99 | 34 | 70 | 22 | 7 | 27 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 38 | 49 | 64 | 71 | 80 | 53 | 48 | 57 | 59 | 73 |
| Inventory Days | 77 | 113 | 119 | 105 | 242 | 1063 | 1152 | 1361 | 1033 | 928 |
| Days Payable | 395 | 462 | 522 | 415 | 606 | 621 | 546 | 744 | 377 | 310 |
| Cash Conversion Cycle | -280 | -299 | -339 | -239 | -283 | 495 | 654 | 673 | 715 | 692 |
| Working Capital Days | -64 | -18 | 57 | 70 | 77 | 75 | 75 | 48 | 26 | 22 |
| ROCE % | 12 | 9 | 7 | 7 | 7 | 10 | 10 | 11 | 6 | 6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.12% | 74.12% | 74.24% | 74.25% | 74.25% | 74.27% | 74.27% | 74.27% | 74.33% | 74.33% | 74.33% | 74.33% |
| FIIs | 4.11% | 4.62% | 4.88% | 5.35% | 5.37% | 4.65% | 4.54% | 5.2% | 4.64% | 4.47% | 4.36% | 4.46% |
| DIIs | 0% | 0% | 0% | 0.06% | 0.09% | 0.14% | 0.18% | 0.2% | 0.2% | 0.2% | 0.25% | 0.3% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.35% | 10.66% | 10.4% | 9.97% | 10.09% | 10.78% | 10.67% | 11.2% | 11.74% | 11.73% | 11.52% | 12.12% |
| Others | 10.42% | 10.6% | 10.49% | 10.37% | 10.2% | 10.16% | 10.34% | 9.13% | 9.11% | 9.29% | 9.54% | 8.79% |
| No. of Shareholders | 50225 | 49495 | 49858 | 49315 | 51479 | 52328 | 52895 | 53437 | 53784 | 52495 | 51415 | 50770 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 150.59 | Sell |
| EMA (10) | 149.73 | Sell |
| SMA (20) | 152.47 | Sell |
| EMA (20) | 152.42 | Sell |
| SMA (50) | 159.4 | Sell |
| EMA (50) | 157.48 | Sell |
| SMA (100) | 163.74 | Sell |
| EMA (100) | 161.81 | Sell |
| SMA (200) | 167.53 | Sell |
| EMA (200) | 169.23 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 26.36 | Buy |
| MACD (12,26,9) | -3.4 | Sell |
| Stochastic (14,3,3) | 10.9 | Buy |
| ADX (14) | 35.15 | Buy |
| Williams %R (14) | -80.86 | Buy |
| ATR (14) | 4.45 | High Volatility |
| ROC (12) | -7.74 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 33.67 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:51:06.454154+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Inauguration on Mar 9, 2026 of oncology and advanced radiotherapy at Shalby Hospital, Surat. | [Disclosure Under Reg. 30 Of SEBI (LODR) Regulations, 2015 - Major Development - Inauguration Of Oncology Department Along With Advanced Radiotherapy Facilities At Shalby Hospital, Surat 9 Mar - Inauguration on Mar 9, 2026 of oncology and advanced radiotherapy at Shalby Hospital, Surat.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae858c00-b30c-4523-b7a5-6942b9fc7bb5.pdf) |
| 9 Apr - Shalby issued an SBLC up to USD 13.27 million for step-down subsidiary SAT Inc. | [Giving Guarantees/Indemnity/ Becoming A Surety For Third Party 9 Apr - Shalby issued an SBLC up to USD 13.27 million for step-down subsidiary SAT Inc.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e4a36d9-0ad8-4a95-a7b2-7dea560a7c71.pdf) |
| 8 May - Shalby filed FY2025-26 annual secretarial compliance report, reporting full compliance and no SEBI actions. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 8 May - Shalby filed FY2025-26 annual secretarial compliance report, reporting full compliance and no SEBI actions.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3b8b2f9d-03af-44f0-ae74-9a5b1e47a4c3.pdf) |
| 5 May - Exercise of Employee Stock Options under Shalby Limited Employees Stock Options Scheme-2021 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 5 May - Exercise of Employee Stock Options under Shalby Limited Employees Stock Options Scheme-2021](https://www.bseindia.com/xml-data/corpfiling/AttachLive/70813dc6-78a6-49eb-8798-fb72d28988ba.pdf) |
| 3 Mar - PK Healthcare (Shalby) Gurugram granted NABH 6th Edition accreditation, valid until 2030. | [NABH Accreditation To PK Healthcare Pvt Ltd. (Shalby International Hospitals) - Subsidiary Company 3 Mar - PK Healthcare (Shalby) Gurugram granted NABH 6th Edition accreditation, valid until 2030.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be68b119-3fba-4c49-943c-e5e398ba4f0f.pdf) |
| 3 Apr - Submitted Regulation 74(5) demat/remat certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Apr - Submitted Regulation 74(5) demat/remat certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ac9862a-abe9-4138-bb8e-e4c337928101.pdf) |
| 28 Feb - Subscribed Rs.59.60 crore rights issue; Shalby stake in PKHPL rises from 87.26% to 91.13% on Feb 28, 2026. | [Credit Of Equity Shares By Subsidiary Company On Rights Issue Basis To The Company 28 Feb - Subscribed Rs.59.60 crore rights issue; Shalby stake in PKHPL rises from 87.26% to 91.13% on Feb 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f5b76bab-66da-490c-9422-b2fe1bfc552b.pdf) |
| 23 Mar - Krishna Shalby Hospital launched Oncology Department with advanced radiotherapy on March 23, 2026, in Ahmedabad. | [Inauguration Of Oncology Department Along With Advanced Radiotherapy Facilities At Krishna Shalby Hospital 23 Mar - Krishna Shalby Hospital launched Oncology Department with advanced radiotherapy on March 23, 2026, in Ahmedabad.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d3354a58-2149-42e6-a08a-fddc3d54ccfd.pdf) |
| 17 Apr - Vijay Kedia resigns as Shalby independent director effective April 30, 2026, citing professional commitments. | [Announcement under Regulation 30 (LODR)-Resignation of Director 17 Apr - Vijay Kedia resigns as Shalby independent director effective April 30, 2026, citing professional commitments.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/76277726-d7f6-409e-8010-ff4cf71e2ceb.pdf) |
| 15h - Board meets May 27, 2026 to approve FY26 audited results and consider dividend. | [Board Meeting Intimation for Approving Audited Financial Results (Standalone & Consolidated) For Quarter And Year Ended March 31, 2026, Recommendation Of Dividend, If Any, And Other Business Matters 15h - Board meets May 27, 2026 to approve FY26 audited results and consider dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ad6bdf5a-77c9-487b-8c38-a8518d9c2f79.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d09ff87a-7cb9-491b-8df0-3170f6caa577.pdf) |
| 2026-08-20 | [Weblink Letter To Shareholders Whose Email Ids Are Not Registered Intimating Exact Path Of Annual Report FY 2025-26 And Notice Of 22Nd AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6553d8b9-e2ea-47a6-9a62-c9ca6376725d.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5522536-b024-404b-8c32-814b02392c94.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53212813-f320-4bbe-8b43-baf6c5752f0b.pdf) |
| 2026-08-17 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a7ac2af-64cf-4975-b369-0c78c03f0dc0.pdf) |
| 2026-08-17 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9be4e9e-68f8-400d-9aab-4391e4ace118.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdaafabf-c451-4f60-b373-681b6fb54191.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=594be6ff-4cd5-4896-b609-31e95831e92e.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting Of Financial Results For Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5eb1579d-319b-4859-ab7d-835434257a29.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f0a0ba9-7756-4a03-9add-704961d2f819.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbcd0078-3ca2-4ce2-8aa9-1aeb270425fd.pdf) |
| 2026-06-02 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0625d61-d54f-4c00-91ec-dcf18d52c858.pdf) |
| 2026-02-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bccfcc3-a052-472c-89cd-ce316d9247cd.pdf) |
| 2024-11-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e8c0cc8-4df9-4541-b825-dd5d06923730.pdf) |
| 2024-07-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c170c678-ffa0-489b-9432-46047973d9aa.pdf) |
| 2024-06-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ad8d017-c2a4-426c-b409-14b8e531e2b3.pdf) |
| 2024-02-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63eb2bfe-9c34-4331-a12d-b00a7858b294.pdf) |
| 2023-11-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54195d77-edb1-404d-9f7c-11807b027b44.pdf) |
| 2023-07-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc0b1410-d45e-4366-addc-9e3bab35cce3.pdf) |
| 2023-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce33aed4-58de-4f03-9754-47a8bc94caa7.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc620aea-f418-45c5-ba4b-c188ca31906b.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ae8ae30-0cbc-460f-8b92-0eda8fc22fd7.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4765ccdd-586d-4cc9-8a90-d3422e4e9cb3.pdf) |
| 2025-11-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23242608-05fd-45dd-8fe4-04956485b408.pdf) |
| 2025-11-15 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5601eb90-3464-41be-9c61-2afd1b854ed1.pdf) |
| 2025-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc2d469e-c9e1-4cf2-8e07-5a5cd464f191.pdf) |
| 2025-05-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5947a23d-268a-47b6-8769-610328aa5326.pdf) |
| 2024-10-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fcbcf73-cb0a-4106-b68b-021de2da8b5c.pdf) |
| 2024-07-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f53afb-f015-4975-aecc-64e1b4d8c867.pdf) |
| 2024-05-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84734df3-f909-4357-b5b4-43c9b36ef8c7.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Financial Results For Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71fc04a2-b085-4bbb-ba84-af333b3706ac.pdf) |
| 2025-02-03 | [Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ef1a263-2e02-4508-8aca-943d75c482dd.pdf) |
| 2024-10-30 | [Unaudited Financials Results For Q2 & H1 FY25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=375ac9bb-9d7e-48f6-b564-3b1869ed791e.pdf) |
| 2024-07-08 | [Results-Unaudited Financials Results For Q1FY2024-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48286c76-412b-4d50-a6a8-9340313e1bd3.pdf) |
| 2024-05-28 | [Outcome Of Board Meeting Q4FY2023-24-Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d61af88c-3ce5-4b90-93f2-9f884a487782.pdf) |
| 2024-02-07 | [Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef4b0d09-2df1-4131-855f-765dd738b8d4.pdf) |
| 2023-10-27 | [Financial Results For Quarter And Half Year Ended September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a959ff8c-ca15-4daa-8bd9-e424f40a7e73.pdf) |
| 2023-07-20 | [Financial Results For Quarter Ended June 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd77e1c9-5064-43e2-94d5-ec7b4cdc67fa.pdf) |
| 2023-07-20 | [Board Meeting Outcome for Outcome Of Board Meeting For Unaudited Financial Results For Quarter Ended June 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=595c0880-6c5a-4e22-987a-5d70974a86de.pdf) |
| 2023-05-18 | [Audited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0691e0f2-d82b-4ce8-b3bb-9c36a5bc0075.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae06539e-0efc-46ef-9283-eb1cfb3732a6.pdf) |
| 2026-05-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01320b6f-dfaa-4121-935a-de3a56deedb5.pdf) |
| 2026-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44900778-c606-4867-afa7-a1573e00c103.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8d378e5-f71f-4c0e-9e5d-5fdd8967f27e.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c42a3fb8-2010-45b2-8c34-fbf209c5e3f6.pdf) |
| 2025-05-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca1251c4-81b5-4904-aa3d-12f8db0711fa.pdf) |
| 2025-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=525e93ef-0313-496d-975b-67e591a867f2.pdf) |
| 2024-10-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d1c15e4-3d5e-420c-843b-208a7bcc9881.pdf) |
| 2024-07-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a787f5f-af00-4eb1-974c-2acac75bb73c.pdf) |
| 2024-05-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a13b8816-0a5b-44af-b668-38472b34841d.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5075fae0-c4e0-41ed-a93f-495406485013.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5075fae0-c4e0-41ed-a93f-495406485013.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0135df2d-e426-4c81-8e2f-a60bd785fb5f.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=389410c1-bf50-435a-80fc-46b5e8d92580.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/389410c1-bf50-435a-80fc-46b5e8d92580.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4e8c0cc8-4df9-4541-b825-dd5d06923730.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/54195d77-edb1-404d-9f7c-11807b027b44.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/01320b6f-dfaa-4121-935a-de3a56deedb5.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/01320b6f-dfaa-4121-935a-de3a56deedb5.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce33aed4-58de-4f03-9754-47a8bc94caa7.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c177436f-41e0-4416-8db9-5a2fbd243dcc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e0cf5ca7-f435-4bd0-a13b-8fd267488e89.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c9780f5-c95d-4195-8ee6-9ef5766749ff.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/540797/75172540797.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:36:11.927Z.